Press Releases

Samsung BIO Insight

Building a Sustainable Future from the Ground Up

BIO CAMPUS2 - Bio Campus II, the future location of Plants 5-8 image1

Bio Campus II, the future location of Plants 5-8


While the world continues to face mounting pressure to alter the trajectory of global warming, many companies are taking concerted climate action toward reducing their carbon footprint and implementing more sustainable practices. As part of our mission to build a more sustainable future for all, Samsung Biologics is adopting systems that reduce energy consumption and recycle waste throughout our current and future plants.


“As we continue to expand our capacity, we knew it was imperative that any new plants we built would now seriously impact our net-zero transition by 2050 or earlier,” said Hyeonsoo Min, Lead Engineer in the Plant 5 Task Force. “That’s why when designing Plant 5, we really tried to think outside the box on how we could bring this plant online without compromising our Scopes 1* and 2* emission reduction goals.”



* Scope 1: All direct emissions from activities of the company and under the control of Samsung Biologics.

* Scope 2: Indirect emissions created through purchased energy and used by Samsung Biologics for company operations.



 Embracing a low-carbon design 

When designing our new Plant 5, the Samsung Biologics team took a low-carbon approach by optimizing all energy sources and choosing recyclable building materials, including high-performance insulation that significantly reduces energy consumption. Once it becomes operational in April 2025, Plant 5 will use nearly 20% renewable energy across all operations, and it is expected to reduce the company’s carbon footprint by nearly 20% compared to its existing plants.


11,000 tCO2eq of GHG reduced with our sustainable design, 1,163 MWh of energy saved annually using solar panerls, 15,000m2 areas where low-carbon concrete will be applied



In terms of the building’s infrastructure, Samsung Biologics plans to use low-carbon green concrete, which contains 50% less carbon than traditional concrete, on 15,000  of the total Bio Campus II. A megawatt-hour (MWh) solar power generator will be installed on the plant’s roof to save more than 1,163 MWh in a year.


Besides a reverse osmosis (RO) water treatment system, which reuses the wastewater generated from manufacturing water for injection (WFI), sustainable operation systems using geothermal power and municipal hot water have also been implemented into the facility’s structure, with the benefit of reducing over 11,000 tCO2eq of GHG emissions as well as operating costs.


“Plant 5 is designed to facilitate the transition to renewable energy from construction to future operations and to achieve our net-zero goal. We will continue our efforts to increase on-site renewable energy generation,” Min explained.



 Paving the way for a greener future 

Samsung Biologics recently published its annual ESG report, reflecting the company’s latest sustainability efforts. As part of the company’s mission to deliver net zero by 2050 or earlier, Samsung Biologics established new milestones: to cut 32% of Scope 1 and 2 emissions by 2030 and 62% by 2040.


In April this year, Samsung Biologics established an enhanced recycling area in Bio Campus I called the Green Center, aiming to achieve an 80% recycling rate. This facility will also be added to future manufacturing sites. The company introduced RFID technology to improve medical waste management efficiency by automatically identifying and tracking hazardous medical waste.


“With these sustainable practices, we are further strengthening our commitment to energy efficiency, renewable energy, and the reduction of our environmental footprint. We are taking steps toward a greener future while reducing costs and generating positive savings,” Min said.


As a leading sustainable CDMO partner, Samsung Biologics understands the seriousness of climate change and its impact on public health; therefore, we are stepping up to the challenge of leading our industry toward a more sustainable future.


“Just as our partners trust us to deliver the highest quality biomedicines, we are committed to building on that foundation to deliver sustainable outcomes,” he added.



BIO CAMPUS2 - Bio Campus II, the future location of Plants 5-8 image2
 


  Driven. For a Sustainable Life.  




 Related contents 

   Posters  Plant 5 brochure  

   Press release  Samsung Biologics releases 2023 ESG report  

   Sustainability  2023 ESG report  


BIO CAMPUS2 - Bio Campus II, the future location of Plants 5-8 image1

Bio Campus II, the future location of Plants 5-8


While the world continues to face mounting pressure to alter the trajectory of global warming, many companies are taking concerted climate action toward reducing their carbon footprint and implementing more sustainable practices. As part of our mission to build a more sustainable future for all, Samsung Biologics is adopting systems that reduce energy consumption and recycle waste throughout our current and future plants.


“As we continue to expand our capacity, we knew it was imperative that any new plants we built would now seriously impact our net-zero transition by 2050 or earlier,” said Hyeonsoo Min, Lead Engineer in the Plant 5 Task Force. “That’s why when designing Plant 5, we really tried to think outside the box on how we could bring this plant online without compromising our Scopes 1* and 2* emission reduction goals.”


* Scope 1: All direct emissions from activities of the company and under the control of Samsung Biologics.

* Scope 2: Indirect emissions created through purchased energy and used by Samsung Biologics for company operations.



 Embracing a low-carbon design 

When designing our new Plant 5, the Samsung Biologics team took a low-carbon approach by optimizing all energy sources and choosing recyclable building materials, including high-performance insulation that significantly reduces energy consumption. Once it becomes operational in April 2025, Plant 5 will use nearly 20% renewable energy across all operations, and it is expected to reduce the company’s carbon footprint by nearly 20% compared to its existing plants.


11,000 tCO2eq of GHG reduced with our sustainable design, 1,163 MWh of energy saved annually using solar panerls, 15,000m2 areas where low-carbon concrete will be applied
 


In terms of the building’s infrastructure, Samsung Biologics plans to use low-carbon green concrete, which contains 50% less carbon than traditional concrete, on 15,000  of the total Bio Campus II. A megawatt-hour (MWh) solar power generator will be installed on the plant’s roof to save more than 1,163 MWh in a year.


Besides a reverse osmosis (RO) water treatment system, which reuses the wastewater generated from manufacturing water for injection (WFI), sustainable operation systems using geothermal power and municipal hot water have also been implemented into the facility’s structure, with the benefit of reducing over 11,000 tCO2eq of GHG emissions as well as operating costs.


“Plant 5 is designed to facilitate the transition to renewable energy from construction to future operations and to achieve our net-zero goal. We will continue our efforts to increase on-site renewable energy generation,” Min explained.



 Paving the way for a greener future 

Samsung Biologics recently published its annual ESG report, reflecting the company’s latest sustainability efforts. As part of the company’s mission to deliver net zero by 2050 or earlier, Samsung Biologics established new milestones: to cut 32% of Scope 1 and 2 emissions by 2030 and 62% by 2040.


In April this year, Samsung Biologics established an enhanced recycling area in Bio Campus I called the Green Center, aiming to achieve an 80% recycling rate. This facility will also be added to future manufacturing sites. The company introduced RFID technology to improve medical waste management efficiency by automatically identifying and tracking hazardous medical waste.


“With these sustainable practices, we are further strengthening our commitment to energy efficiency, renewable energy, and the reduction of our environmental footprint. We are taking steps toward a greener future while reducing costs and generating positive savings,” Min said.


As a leading sustainable CDMO partner, Samsung Biologics understands the seriousness of climate change and its impact on public health; therefore, we are stepping up to the challenge of leading our industry toward a more sustainable future.

“Just as our partners trust us to deliver the highest quality biomedicines, we are committed to building on that foundation to deliver sustainable outcomes,” he added.


BIO CAMPUS2 - Bio Campus II, the future location of Plants 5-8 image2
 


  Driven. For a Sustainable Life.  




 Related contents 

   Posters    Plant 5 brochure  

   Press release    Samsung Biologics releases 2023 ESG report  

   Sustainability    2023 ESG report  


SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION